Tag: tumor

New Investigational Helmet Device Shrinks Glioblastoma

A case report describes a novel helmet device that generates a noninvasive oscillating magnetic field and that shrunk a glioblastoma tumor by about a third....

Liver Cancer Monotherapy Indication for Nivolumab Withdrawn

The indication for nivolumab (Opdivo) as monotherapy for hepatocellular carcinoma (HCC) for patients previously treated with sorafenib has been voluntarily withdrawn by the manufacturer, Bristol-Myers...

Building a Better FIT Test for Colon Cancer Screening

NEW YORK (Reuters Health) – An antibody-based multitarget fecal immunochemical test (mtFIT) for colorectal cancer (CRC) screening is more accurate in detecting advanced neoplasia compared...

Latest FDA Pembrolizumab Approval Expands Label to Cutaneous SCCs

The Food and Drug Administration has approved pembrolizumab (Keytruda) monotherapy for locally advanced cutaneous squamous cell carcinoma (cSCC) that can’t be cured by surgery or...

Are Oncologists Liable for Pandemic-Related Treatment Delays?

Albuquerque oncologist Barbara McAneny, MD, has a patient in his 30s who experienced rectal bleeding for 6 months last year but didn’t see a physician...

Health Policy Expert Peter Bach, MD, Goes to Biotech Company

A well-known healthcare policy expert whose work has focused on the cost and value of anticancer drugs has left academia and has accepted a position...

One Quarter of 30–49-Year-Olds Have Abnormal Colonoscopy Results

More than one quarter of colonoscopies carried out in Americans aged 30 to 49 years reveal some type of neoplasm, and slightly over 6% of...

MD Charged With Manslaughter Now Faces Malpractice Suit

An Alabama neurosurgeon who was charged with manslaughter in the death of a third-year medical student is now facing a malpractice suit alleging he performed...

IL-6 Levels Predict Distant Breast Cancer Recurrence

The inflammatory cytokine interleukin 6 may be a biomarker for distant recurrence of breast cancer among patients treated for stage II-III HER2-negative disease, investigators have...

Pandemic Leads Doctors to Rethink Unnecessary Treatment

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Covid-19 is opening the door for researchers to address a problem...

Chemoimmunotherapy in Invasive Lobular Breast Cancer

The PD-L1 inhibitor atezolizumab (Tecentriq) combined with carboplatin has shown signs of clinical activity in women with metastatic invasive lobular breast cancer (ILC) according to...

Better Survival After Lumpectomy Plus RT vs Mastectomy

Overall survival and breast cancer–specific survival were consistently better for women with early breast cancer who were treated with breast conservation surgery (BCS) followed by...

FDA Panel Votes Against Two Cancer Indications but Backs 4 of 6

Federal advisers this week supported the efforts of pharmaceutical companies in 4 of 6 cases in which these firms are fighting to maintain cancer indications...

Made-to-Order TILs Effective Against Metastatic Melanoma

In just over one third of patients with metastatic melanoma who had experienced disease progression while receiving multiple prior lines of therapy, including immunotherapy and...

Negative Results When Immunotherapy Was Added Onto Radiation

The early halt of a phase 3 trial of avelumab (Bavencio) plus chemoradiotherapy for the treatment of squamous cell head and neck cancer raises a...

Weight Gain Common in Childhood Brain Tumor Survivors

Children who have been treated for brain tumors often experience significant weight gain, and new findings suggest that this could be a sign of hypothalamic-pituitary...

No Survival Benefit to Primary Resection Before Chemo in CRC

NEW YORK (Reuters Health) – Contrary to previous reports, primary tumor resection prior to chemotherapy did not confer a survival benefit in colorectal cancer patients...

US Cancer Drug Approvals Ensure Access but Not Value

Cancer drugs that have been approved in the United States are often not immediately approved in the United Kingdom and Canada, owing to uncertainty over...

Liquid vs Tissue Biopsy in Prostate Cancer: Why Not Both?

The genomic landscape of circulating tumor DNA (ctDNA) was comparable to the landscape of tissue biopsies in a large study of patients with metastatic castration-resistant...

Which Patients With Kidney Cancer Are Likely to Respond to ICI?

Several factors associated with a diminished response to immune checkpoint inhibitor (ICI) drugs among patients with metastatic clear cell renal cell carcinoma (ccRCC) have been...

Obesity ‘Clearly’ Not Tied to Worse Survival in MBC

The relationship between obesity and overweight and breast cancer has some elements of mystery. But this is not one of them: in metastatic breast cancer...

First Mammography Guidelines for Older Breast Cancer Survivors

The first guidelines ever released for screening mammography for older survivors of breast cancer (>75 years) recommend that routine mammography be discontinued for women whose...

Gut Microbiome Predicts Nivolumab Efficacy in Gastric Cancer?

Preliminary data suggest that a certain pattern of gut microbes may be useful in predicting which patients with advanced gastric cancer are likely to benefit...

HPV Throat Cancer and Oral Sex at Younger Age, Multiple Partners

Having oral sex with more than 10 previous partners was associated with a 4.3 times’ greater likelihood of developing human papillomavirus (HPV)–related oropharyngeal cancer, according...

A Reflection of a Life-Threatening Condition

When a 47-year-old woman with well-controlled schizophrenia attended the Smell and Taste Research Clinic in Chicago, Illinois, Justin Virk, MD, had no idea he was...